Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
nmills convenienltly left out the rest of her linkedin profile showing she has over 4.5 years in IR/PR
Senior Account Executive; Account Executive
Weber Shandwick
October 2012 – January 2015 (2 years 4 months)New York, NY
Weber Shandwick is a leading global public relations firm with offices in 81 countries. The firm’s diverse team of thinkers, strategists, analysts, producers, designers, developers and campaign activators has won the most prestigious awards in the world for innovative, creative approaches and impactful work, including being honored as a 2014 Ad Age A-List Agency and winning four 2013 Cannes Lions. Weber Shandwick was also named PRWeek’s International Consultancy of the Year and The Holmes Report’s Best Healthcare Consultancy in the World in 2013, in addition to earning numerous best place to work accolades. The firm deploys deep expertise across sectors and specialty areas, including consumer marketing, corporate reputation, healthcare, technology, public affairs, financial services, corporate social responsibility, financial communications and crisis management, using proprietary social, digital and analytics methodologies. Weber Shandwick is part of the Interpublic Group (NYSE: IPG). For more information, visit www.webershandwick.com.
Assistant Account Executive; Intern
ICR
January 2011 – October 2012 (1 year 10 months)Norwalk, CT
ICR is a recognized leader in financial communications specializing in investor relations and corporate communications. In just over a decade, it has become the #1 ranked independent financial communications firm in North America, with a growing presence in Asia. ICR was ranked the eighth largest independent communications firm by PR Week's 2012 Agency Business Report
World Moto, Inc. Retains KCSA Strategic Communications as Investor Relations Counsel
KCSA, a leading New York-based communications firm, will deploy a comprehensive investor relations campaign to help achieve a fair valuation of World Moto's equity, build a resilient shareholder base and increase awareness of the Company among the investment community.
http://www.prnewswire.com/news-releases/world-moto-inc-retains-kcsa-strategic-communications-as-investor-relations-counsel-300078288.html
nmills you must have friends who work at facebook to be able to get that kind of information. (I call bullsh*t)
Gotta love the post split rally in the stock and how Howard is always creating new opportunities
Need a Quick Fix? First Express Starbucks Lands in NYC - http://www.wired.com/2015/04/need-quick-fix-first-express-starbucks-lands-nyc/
nmills you make no sense unless you are shorting the stock. New investors would drive the s/p up. Is that something you are opposed to?
So says the guy who swore gum in Thailand was 2 cents (real price: 30 cents)
Downloads are moving up
Installs
50 - 100
You first Sujita.
I thought you knew everything about Thailand Sujita. By the way, a pack of sum does now cost 2 cents as you spout here.
Gum (Dentyne), regular size (12.6 grams) ranges from 10-12 THB or 30-37 cents (USD). A large pack of gum (49 grams) ranges from 45 THB to 52 THB or $1.38 USD to $1.54 USD.
Just to note that mom & pop shops can be more expensive, and prices can range between supermarkets, sizes and brands/flavors.
Please stop pretending to know all about Thailand when clearly you don't.
Sujita it's so great to see you agree that there is a market for YES. Thank again.
Just waiting on your example of a faster delivery service in BK. Waiting...
Still waiting for your answer Sujita.
Show me one delivery service that is faster in Bangkok. ONE.
Reading your post, I assume you have never been to a major US city. They too have stores below.
One more thing, YES is a disruptive technology that delivers in 9 minutes or less. See their video on the PR
Sujita - you are wrong. UBER Eats is looking at deliveries in the $8 to $12 range.
http://www.cnbc.com/id/102623609
Seems to me that there are pizza and Chinese deliveries available in Chicago and New York too.
Get over what you think you know and take a look at what is really happening out there.
It's a brave new world.
Sujita - The fact that there is are lots of delivery options, proves that there is a delivery market.
So clearly we can agree there is a market. Thank you Sujita.
So there must be money to be made. Thank you again.
So their biz model is to use motorcycle taxis directly therefore impacting the current model by the same token that UBER is using taxis to deliver lunch in Chicago and New York.
Your numbers are flawed. YES could be a very big deal.
Look at similar opportunities in the US such as PeaPod or Instacart which is doing over a million a week
http://www.forbes.com/sites/erikamorphy/2015/02/16/instacart-is-retails-new-best-friend-just-ask-whole-foods/
http://www.runtri.com/2013/03/mobile-commerce-results-30-of-total.html
Where are you getting your short report?
http://otcshortreport.com/index.php?index=FARE.OB
http://www.otcmarkets.com/stock/FARE/short-sales
There's a good use of $12,000.
OSC probing CEN Biotech
It is not known when the OSC investigation into the company began. Given that the matter involves an OTC-listed company operating in Canada, it is likely that the OSC is working in conjunction with U.S. regulators since that is typically how the regulator conducts such probes.
http://www.theglobeandmail.com/report-on-business/ontario-securities-commission-probing-marijuana-firm-cen-biotech/article23622472/
I have been to many LP applicant's operations. So have many media outlets. What a joke
What do you expect from an expat who has already been fingered as an ex-employee?
Actually it's not Aegis. Read the filings.
LOL
The same SEC that just put the company through the rigors of an S1?
Selling? Who. Not insiders.
Ah Sujita. You're an ex-pat with an ax to grind like so many ex-pats.
Where is the SEC on this?
Different paul giles - Christ you are a jerk
What? No way! I am in shock! Where's my t shirt?
Buh Bye. I feel sorry to those of you who actually believed anything that miserable liar was spouting. From day one, it has been apparent that this was nothing but a scam. 1.3 million pounds? Come on.
You're fixated on Smyth. He's only a consultant. As for being blocked on email, maybe there is a reasonable explanation.
You do realize by bashing here that newbies will see your posts and be less interested in buying thereby diminishing the value of your purchases?
Nope. They now want LP's to grow a test harvest first. So once any LP Applicant gets the green light, then it's still 6 to 8 months out. Depressing.
here you go . google really is easy to use http://www.courthousenews.com/2015/02/06/SECvCaledonianBank.pdf
So. there is a thing called google.
http://www.courthousenews.com/2015/02/06/sec-goes-after-a-cayman-islands-bank.htm
Google. It might be new for you. Type in your browser www.google.com
SEC Goes After a Cayman Islands Bank linked to Nostra and others
MANHATTAN - Cayman Islands-based Caledonian Bank and four other companies took more than $75 million from unregistered sales of "virtually worthless" penny stocks, the SEC claims in court.
The SEC on Friday sued Caledonian Bank, Caledonian Securities, Clear Water Securities, Legacy Global Markets, and Verdmont Capital, in Federal Court.
The Caledonian defendants are based in the Cayman Islands. Clearwater and Legacy are based in Belize, Verdmont in Panama.
All of the scams were the same, the SEC says in its 39-page complaint. First, they filed "bogus registration statements" with the SEC, purporting to register securities to public shareholders, though there were no such sales and the securities stayed in the control of the issuers and their affiliates.
"In the sham offerings, the issuers pretended to sell securities to shareholders in such places as Serbia, Mexico, Ireland, Norway, Panama and Jamaica," the SEC says.
The restricted securities were then "passed off" as free-trading stocks in the United States and sold to the public, the SEC says in the lawsuit.
The agency claims the defendants operated as affiliates, dealers, sales outlets and underwriters, in connection with four shell companies: Swingplane Ventures, Goff Corp., Nostra Energy and Xuamnii Inc.
"(T)hese violations occurred simultaneously with aggressive and extensive promotion campaigns for the penny stocks of those shell companies," the SEC said. "The defendants' unregistered sales of securities generated more than $75 million in proceeds on penny stocks that were virtually worthless and whose prices fell to their former token levels within months of the defendants' sales."
The SEC seeks disgorgement, restitution, penalties and an injunction.
SEC Goes After a Cayman Islands Bank linked to Nostra and others
MANHATTAN - Cayman Islands-based Caledonian Bank and four other companies took more than $75 million from unregistered sales of "virtually worthless" penny stocks, the SEC claims in court.
The SEC on Friday sued Caledonian Bank, Caledonian Securities, Clear Water Securities, Legacy Global Markets, and Verdmont Capital, in Federal Court.
The Caledonian defendants are based in the Cayman Islands. Clearwater and Legacy are based in Belize, Verdmont in Panama.
All of the scams were the same, the SEC says in its 39-page complaint. First, they filed "bogus registration statements" with the SEC, purporting to register securities to public shareholders, though there were no such sales and the securities stayed in the control of the issuers and their affiliates.
"In the sham offerings, the issuers pretended to sell securities to shareholders in such places as Serbia, Mexico, Ireland, Norway, Panama and Jamaica," the SEC says.
The restricted securities were then "passed off" as free-trading stocks in the United States and sold to the public, the SEC says in the lawsuit.
The agency claims the defendants operated as affiliates, dealers, sales outlets and underwriters, in connection with four shell companies: Swingplane Ventures, Goff Corp., Nostra Energy and Xuamnii Inc.
"(T)hese violations occurred simultaneously with aggressive and extensive promotion campaigns for the penny stocks of those shell companies," the SEC said. "The defendants' unregistered sales of securities generated more than $75 million in proceeds on penny stocks that were virtually worthless and whose prices fell to their former token levels within months of the defendants' sales."
The SEC seeks disgorgement, restitution, penalties and an injunction.
Profit taking by the day traders who jumped on the stock yesterday. Check $FARE on twitter
FITX bagholders = Jim Jones followers.
From day one when they came out with 1.3 million lbs a year, anyone in the industry knew they were full of it.
CEN Biotech invented employee to dispute claims
The strange saga of CEN Biotech, the company seeking to become Health Canada’s largest producer of medical marijuana, has taken a bizarre new twist: The company has been caught creating a fake employee, and issued a press release quoting the made-up person.
CEN Biotech, which has made it to the final stage of a licencing process Health Canada describes as “rigorous,” issued the phony press release last month after an investigation by The Globe and Mail uncovered numerous examples of the company misrepresenting itself to the public, and using Health Canada’s name to make inaccurate claims about its business.
But the company had in fact created the identity of Mr. Weber. A Toronto public relations firm that cut ties with CEN Biotech late last week said it learned about questionable conduct by the company – including an admission that CEN Biotech executives were lying about the existence of Isak Weber – and has refused to work with them.
"We thrive with clients who are open and transparent with us,” said Jeff Bangs, partner at Toronto-based Pathway Group, which specializes in government relations and public affairs. “But as professionals we do not condone fabricating an employee for the sole purpose of polishing a client's reputation when they're under scrutiny."
The revelation raises questions about Health Canada’s oversight of this new sector – estimated to be a future multibillion-dollar industry. The government is doling out licences worth as much as $70-million on the stock market, but there are questions as to how much Health Canada knows about the companies it is licencing. Health Canada says it does “extensive” checks on company personnel before issuing a licence, but this is now being called into question with the CEN Biotech situation.
The Globe's investigation uncovered numerous false claims made by CEN Biotech in the past 14 months, including misrepresentations to investors about its licence status with Health Canada and suggestions it was being favoured by the government. Since then, Health Canada officials said the department wasn’t responsible for looking into the problems and therefore was going to sit on the sidelines. Even though Health Canada holds sole authority over the granting of the licence, government officials said it was the responsibility of the public to inform the police of any concerns.
It is not clear whether evidence of a fabricated company official is enough for Health Canada to call into question CEN Biotech’s licence application. Health Canada won’t comment.
Until now, the company has not owned up to the identity of Isak Weber. However, when the Globe asked the company’s CEO, Bill Chaaban, on Tuesday if Mr. Weber was real, Mr. Chaaban sent an e-mailed response saying, “Isak Weber is a nom-de-plume” for an employee. He compared the situation to when CEOs have speeches written by others. “There are also many corporations that adopt an identity,” Mr. Chaaban said, listing off “Ronald McDonald,” “Mr. Clean” and “Mr. Goodwrench“ as examples.
It is not clear why the company feels it needs a “nom-de-plume” for its employees, nor why the mascot explanation was given. In the case of McDonald’s Corp., for example, the hamburger chain doesn’t use Ronald McDonald to speak on behalf of the CEO on important matters involving press releases issued to the stock market.
Health Canada unveiled its new privatized medical marijuana sector in April, opening the industry to large-scale businesses, and CEN Biotech has applied to be the federal government’s largest player with an application to grow 600,000 kilograms a year. At an investor conference in 2014, Mr. Chaaban touted how close the company was to Health Canada, claiming that he had committed to “partner with them to build the industry.”
Pathway Group doesn’t usually speak publicly about its clients, but Mr. Bangs said the unusual circumstances required an explanation for severing ties with CEN Biotech to preserve his firm’s integrity. "Pathway Group resigned the CEN Biotech account on January 23rd and no longer has any affiliation with that company,” Mr. Bangs said.
It marks the second time in less than a month that CEN Biotech has been dropped by a public relations firm over concerns about the accuracy of the company’s statements.
CEN, which is the Canadian subsidiary of Michigan-based Creative Edge Nutrition, was dropped by New York-based 5WPR on Dec. 31, after the investor relations firm found the company had issued press releases under 5WPR’s name without its knowledge or approval.
One of those problematic press releases was the one that introduced the fictitious Isak Weber. CEN Biotech released that document to the markets on Dec. 21 to address “shareholder questions” raised by The Globe’s investigation.
The Globe found CEN Biotech has made claims in press releases, interviews and at industry conferences that have exaggerated the company’s position in the market, including that it had obtained or was close to obtaining a licence that would make it the largest producer of medical marijuana in the world. Those claims helped push the company’s shares up more than 2,000 per cent. Health Canada warned the company about these claims early last year, but never followed up on subsequent problems. Meanwhile, Mr. Chaaban was selling off more than 71-million shares in 2014, netting significant profit, since he acquired his stock as an insider for next to nothing. Mr. Chaaban sold at least $4.6-million (U.S.) worth of stock through several dozen large share sales.
Mr. Chaaban has attempted to cloud the picture in recent weeks, sending a lengthy letter to Health Canada and Health Minister Rona Ambrose, in which he claims The Globe’s investigation is incorrect. However, in this letter to Health Canada, Mr. Chaaban makes further false claims, including denying he had done an interview with The Globe for which there is a recording, and claiming, wrongly, that the Globe had misquoted a company press release that is readily available on the Internet.
When the Globe pointed out these inaccuracies, and numerous other misleading statements in his argument, Mr. Chaaban told the Globe in a subsequent letter that he was mistaken. “This was in error,” Mr. Chaaban said of his denial of the interview, and his claims that the press release was misquoted. However, Mr. Chaaban did not send this subsequent letter to Health Canada or Ms. Ambrose.
The inaccuracies in Mr. Chaaban’s first letter are significant though, since it means that Health Canada is now in possession of misleading documents sent directly to the department and the minister. To date Health Canada has tried to distance itself from the problems.
Mr. Chaaban also said it was he who severed ties with 5WPR in New York, which is a claim the company’s president Ronn Torossian calls “categorically untrue,” noting that he had to demand Mr. Chaaban remove his company’s name from the CEN website, which took several days.
Among, Mr. Chaaban’s most confusing claims in recent weeks, however, is that the company has been in a so-called “quiet period” mandated by the U.S. Securities and Exchange Commission relating to a forthcoming deal to spin-off CEN Biotech into a separate company, and has therefore been unable to answer The Globe and Mail’s questions about questionable conduct. However, despite this claim of a quiet period, Mr. Chaaban has been actively conducting interviews, including a phone call with The Globe two weeks ago where he said the allegations facing his company were “an attack on my character.” He also conducted interviews with three media outlets in the Windsor, Ont., area where the company is looking to operate.
It is not clear why Health Canada hasn’t stepped in to address the problems facing its largest licence applicant. Beyond the evidence of false or exaggerated statements, and the fabrication of Isak Weber, documents filed with regulators over the past two years show six distinctly different signatures attributed to Mr. Chaaban, with little explanation for the discrepancies.
In his conversation with The Globe two weeks ago, Mr. Chaaban shrugged off the evidence of multiple signatures on company documents, saying the way he signs his name “depends on the mood I’m in.” He also joked about having multiple personalities, and questioned whether Canada had become communist for questioning the $4.6-million he made selling his own shares as an insider.
In an e-mail Tuesday, Mr. Chaaban acknowledged his original statement on the signatures was “flippant” adding, “I can understand why you would pursue this.” He said: “The simple reason they [the signatures] differ is that I don’t want my signature to be forged and it could be if countless documents are publicly available with the same signature that I have on file elsewhere, such as at the bank.” However, senior executives at publicly traded companies routinely sign documents filed with regulators.
The creation of a fake persona to speak for CEN Biotech is perhaps the most troubling development surrounding Canada’s biggest medical marijuana applicant. Since Dec. 21, The Globe has asked the company and its representatives several times for an interview with Mr. Weber but to no avail.
In touting his company, Mr. Chaaban has listed several people associated with CEN Biotech – as directors and experts – as evidence of the company’s credibility. Those people include doctors, lawyers, and a former financial industry whistle blower named John Germinario, who runs New York-based Global Securities Services Corp.
At an industry gathering in 2014, Mr. Chaaban described Mr. Germinario as the person who “screens every transaction now going forward, and the ones in the past that we’ve entered into, and ensures that it’s in the best interest of shareholders and it’s legal.”
Reached at his office early Monday afternoon and questioned about the validity of Isak Weber, Mr. Germinario said he was told by Mr. Chaaban that Isak Weber was a real person.
“I asked Bill who Isak Weber was. He was a new hire and he’s in Canada,” Mr. Germinario said. Asked if he’d ever met Mr. Weber, Mr. Germinario said, “No.”
However, Mr. Chaaban said Tuesday that Isak Weber is the nom-de-plume for a man named Roger Glasel, “who is an employee.” He added, “It would have been improper to call him by an identifiable name, but a neutral name was chosen.” It is not clear why the company could not identify Mr. Glasel as the employee speaking for the company.
Health Minister Rona Ambrose’s office did not respond to a request for comment.
In recent weeks, NDP health critic Libby Davies and deputy Liberal leader Ralph Goodale called on the government to halt the company’s licence application to investigate the concerns.
NEWS: Moto-Meter(TM) Ready for Global Sales
NEW YORK, NY--(Marketwired - Jan 28, 2015) - World Moto, Inc. (OTCBB: FARE) (OTCQB: FARE) (BERLIN: WM7) (BERLIN: A1J8SY) ("World Moto" or the "Company") today announced that it is now immediately accepting orders from qualified global distributors and fleet operators for the Moto-Meter™.
The global opening of sales comes after several months of rigorous testing on the streets of Bangkok and with select partners. The ongoing quality assurance process has demonstrated that the Moto-Meter™ can withstand the extreme hazards that it will be subjected to in the field. The testing has additionally demonstrated that not only is the ruggedized device capable of withstanding the physical assaults of daily operations, but that the user experience from both passengers and drivers meets the standards that the company has set in order to begin general sales of the product. The Company has worked closely with the StartSmiling Thailand campaign and community (http://startsmiling.me) during this testing phase, and this has afforded an excellent opportunity to gauge public opinion about the Moto-Meter™. The positive response the Company has received from people from all walks of life, including motorcycle taxi drivers, students, celebrities, officials and businesspeople, has exceeded all expectations.
The Company is currently actively pursuing its goal of certifying the Moto-Meter™ with two administrative authorities in preparation for advancing its negotiations on regulatory mandates. Negotiations for legislation mandating the Moto-Meter™ will be pursued in parallel with the general sales process.
The Company believes that the Moto-Meter™ is one of the most sophisticated regulatory devices for transport services available on the market today, and that the features and benefits of the device will lead to its rapid adoption throughout the world. Further information on the enhanced capabilities that have been integrated into the Moto-Meter™ over the last year will be announced in forthcoming press releases.
Fleet operators and distributors interested in purchasing lots of the Moto-Meter™ may contact sales at sales@worldmoto.com. Production devices and delivery schedules will be allocated on a first come, first served basis to qualified operators and organizations.
Note that the World Bank estimates that the numbers of motorcycle taxis will increase by more than 50% over the next five years. Also note that saturation of the Moto-Meter™ is projected to reach 100% within three years of introduction in any given market and that its life expectancy/repurchase cycle is estimated at three years.
Unless you are sitting outside the office, not even sure you can make that statement truthfully
You said they would be out of business six months ago, and yet they are still in business
Read the restated filings. Giles never sold.